Skip to content

Author

E. Dee

We have 5 of 493 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Causes of death across the life course in the Association of Southeast Asian Nations (ASEAN): a systematic analysis for the Global Burden of Disease Study 2023

Summary Background The drivers of mortality and their associated risk factors evolve throughout the course of life. Understanding these transitions is essential for effective, equitable, and age-appropriate health interventions. Methods As part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 20...

Tai-Shun Li, P. Charalampous, S. C. C. van der Lubbe et al. · 1 citation
Open access Sep 2026

Predictors of Delayed and Omitted Postoperative Radiotherapy After Laryngectomy for pT4 Laryngeal Cancer.

BACKGROUND Postoperative radiotherapy (PORT) improves locoregional control and survival in high-risk head and neck cancer, and guidelines recommend initiation within 42 days of surgery. Timeliness after laryngectomy for pathologic T4 (pT4) laryngeal cancer is poorly characterized. METHODS In a retrospective National...

G. Ashji, Arun Rajan, Elias Dahl et al. · 0 citations
Review Open access Sep 2026

Health services research and advocacy in US cancer care: pathways from evidence to implementation

Examination of four US oncology cases spanning state legislation, federal payment reform, patient advocacy, and clinical measurement shows how health services research can influence cancer care when evidence is paired with appropriate policy mechanisms, financing structures, and implementation capacity.

Nipun Gorantla, M. George, N. Swami et al. · 0 citations
Open access Jul 2026

The burden of childhood cancers in the South Asian Association for Regional Cooperation (SAARC) Region: a population-based, cross-sectional GLOBOCAN 2022 analysis

SAARC childhood cancer patterns reflect both population size and health system capacity, with a preponderance of leukemia and marked mortality-to-incidence ratio disparities across countries, especially for CNS cancers.

T. Menon, J. Selvasingh, Taral K. Jella et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.